The Niche’s recommended Weekly Reads on stem cell research and regenerative medicine.
After the good news of Friday that a stem cells for type 1 diabetes therapy appears to be effective in a small trial, we should also note that a second teenager has died after receiving Sarepta’s Elevidys gene therapy for Duchenne muscular dystrophy. The cause of death again was liver failure. Sarepta has limited shipments […]
Despite intense criticism, Colossal Biosciences continues to claim de-extinction of dire wolves. The false claims and hype are such a big mistake. It’s not even necessary either. The firm has a strong scientist in its scientific leader Beth Shapiro. It has George Church. To Colossal, I say that your firm should just say what it
It’s been a crazy week on the cell and gene therapy front. We live in strange times more generally. I just wrote about a Thursday FDA cell and gene therapy roundtable that generally promoted the idea of less oversight. And far more speed to human use. RFK Jr. was present at the end and spoke.
Longevity research is a growing part of the overall regenerative medicine field. Rewinding, when I first started blogging here on The Niche in 2010, longevity was more of a fringe field. In just 15 years, it has become a generally legit area, even if one often filled with hype. It has its share of scammers
There has been a sizable downturn for the CRISPR therapy biotech arena. Firms like Editas, Verve, Intellia, and even CRISPR Therapeutics, which has garnered an FDA approval, have had struggles recently. It feels like a disconnect here in a way because overall gene editing and gene therapy have never seemed more promising. But being a
I recently wrote about the upbeat early reports from two allogeneic trials of stem cells for Parkinson’s. Now there’s additional encouraging early news on this front but using patients’ own cells. This is one of the most promising areas of regenerative medicine. Stem cells for Parkinson’s: Aspen Neuroscience upbeat early data California biotech Aspen Neuroscience
It was another crazy week for me with tons of grant work, but news and research in the regenerative medicine world keep on popping up including a paper on MSCs for MS. I’ve realized that even when I’m trying to take a short break, I often see science and signs of stem cells popping up
Weekly reads: stem cells everywhere, MSCs for MS?, nanostickers, Makary update Read More »
Stem cells can be serious business, but sometimes stories come along that are just fun like a lady running a marathon dressed as a stem cell. How cool is this: “Louise Cato from Somerset is doing the run to raise money for the charity Anthony Nolan, after her dad had a bone marrow transplant over
Weekly reads: stem cell marathon, Ray Therapeutics, stem cells making you fat? Read More »
Some of you may know that gardening is one of my hobbies and I see it as akin to science, even like growing stem cell cultures. Tomatoes are my favorite thing to grow. About ten years ago I started sprouting my own tomato plants from seed. It’s surprisingly easy with grow lights. This way you
Weekly stem cell reads: tomato stem cells, FDA blacklist, CALEC, odd RFK Jr. summit Read More »
What’s life as an academic scientist really like now? It’s gotten worse in the U.S. recently. There’s more stress about funding including on levels that we can’t control. I’m writing too many grant proposals these days. I’m wondering how much researchers are now using AI for grant writing, which I have not done. Does AI
Weekly reads: robot scientist, stem cell sperm make a baby, assembloids & sense Read More »